<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">36743</article-id><article-id pub-id-type="doi">10.17816/dv36743</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">IMPROVEMENT OF THE APPLICATION METHOD FOR THE TREATMENT OF NODULAR BASALE CELL CARCINOMA</article-title><trans-title-group xml:lang="ru"><trans-title>Совершенствование аппликационного метода лечения нодулярной базалиомы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Molochkov</surname><given-names>V. A</given-names></name><name xml:lang="ru"><surname>Молочков</surname><given-names>Владимир Алексеевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>Отделение дерматовенерологии и дерматоонкологии д-р мед. наук, проф.</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Molochkov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Молочков</surname><given-names>Антон Владимирович</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф Отделение дерматовенерологии и дерматоонкологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alieva</surname><given-names>P. A</given-names></name><name xml:lang="ru"><surname>Алиева</surname><given-names>Патимат Магомедовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант Отделение дерматовенерологии и дерматоонкологии</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khlebnikova</surname><given-names>A. N</given-names></name><name xml:lang="ru"><surname>Хлебникова</surname><given-names>Альбина Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф кафедра кожных и венерических болезней</p></bio><email>alb9696@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sedova</surname><given-names>T. G</given-names></name><name xml:lang="ru"><surname>Седова</surname><given-names>Татьяна Геннадьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук кафедра кожных и венерических болезней</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">M.V. Vladimirsky Moscow Regional Research and Clinical Institute</institution></aff><aff><institution xml:lang="ru">МОНИКИ им. М.Ф. Владимирского</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I.M.Sechenov First Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ФППОВ ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2013</year></pub-date><volume>16</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2013)</issue-title><issue-title xml:lang="ru">№2 (2013)</issue-title><history><date date-type="received" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Эко-Вектор"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/36743">https://rjsvd.com/1560-9588/article/view/36743</self-uri><abstract xml:lang="en"><p>Fifty patients with nodular basale cell carcinoma were treated by the application method with selenious acid preparation (0.45% in conversion to selenium). The efficiency of the method reached 96%. Good cosmetic results were attained (re-epithelialization in 72% cases, slight cicatricial atrophy in 28%).</p></abstract><trans-abstract xml:lang="ru"><p>Приведены данные о лечении 50 больных нодулярной формой базалиомы аппликационным методом с помощью препарата селенистой кислоты (0,45% в пересчете на селен). Эффективность метода составила 96%, при этом отмечены хорошие косметические результаты (в 72% случаев — реэпителизация, в 28% — незначительная рубцовая атрофия).</p></trans-abstract><kwd-group xml:lang="en"><kwd>basale cell carcinoma</kwd><kwd>nodular form</kwd><kwd>application therapy</kwd><kwd>Mardil Selenium</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>базалиома</kwd><kwd>нодулярная форма</kwd><kwd>аппликационная терапия</kwd><kwd>Мардил Селен</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Гармонов А.А. Некоторые аспекты патогенеза базальноклеточного рака кожи и его лечение с помощью радиохирургии и иммунокоррекции интефероном: Автореф. дис. канд. мед. наук. М.; 2002.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Писклакова Т.П. Базально-клеточный рак кожи и его классификация. Российский журнал кожных и венерических болезней. 2003; 6: 6—7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Coebergh J.W., Neumann H.A., Vrints L.W., van der Heijden L., Meijer W.J., Verhagen-Teulings M.T. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975—1988: a registry-based study. Br. J. Dermatol. 1991; 125(4): 353—9.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gollnick H., Barona C.G., Frank R.G., Ruzicka T., Megahed M., Maus J., Munzel U. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur. J. Dermatol. 2008; 18(6): 677—82.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chren M.M., Torres J.S., Stuart S.E., Bertenthal D., Labrador R.J., Boscardin W.J. Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study. Arch. Dermatol. 2011; 147(5): 540—4.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Снарская Е.С., Молочков В.А. Базалиома. М.: Медицина; 2003.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sexton M., Jones G.B., Meloney M. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J. Am. Acad. Dermatol. 1990; 23(6, Pt 1): 1118—26.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hendrix J.D., Parlette H.L. Micronodular basal cell carcinoma. A deceptive histologic subtiype with frequent clinicalle andetected tumor extension. Arch. Dermatol. 1996; 132(3): 295—8.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Staub G., Revol M., May P., Bayol J.C., Verola O., Servant J.M. Excision skin margin and recurrence rate of skin cancer: a prospective study of 844 cases. Ann. Chir. Plast. Esthet. 2008; 53(5): 389—98.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Farhadi M., Kamrava S.K., Behzadi A.H., Rafiezadeh P., Asghari A., Rezvan F., Maleki S. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma. J. Drugs Dermatol. 2010; 9(2): 122—6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Walling H.W., Fosko S.W., Geraminejad P.A., Whitaker D.C., Arpey C.J. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev. 2004; 23(3— 4): 389—402.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Lo J.S., Snow S.N., Reizner G.T., Mohs F.E., Larson P.O., Hruza G.J. Metastatic basal cell carcinoma: report of twelve cases with a review of literature. J. Am. Acad. Dermatol. 1991; 24(5, Pt 1): 715—9.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Апатенко А.П. Эпителиальные опухоли и пороки развития кожи. М.: Медицина; 1973.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wade T.R., Ackerman A.B. The many faces of basal-cell carcinoma. J. Dermatol. Surg. Oncol. 1978; 4(1): 23—8.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Frankel A., Goldenberg G. Presentations and treatment of basal cell carcinoma: a review. http://www.bmctoday.net/cutaneouson cologytoday/2011october</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Хлебникова А.Н. Клинико-морфологические и иммуногистохимические особенности базально-клеточного рака кожи и комплексный метод его лечения: Автореф. дис. д-ра мед. наук. М.; 2007.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Молочков В.А., Марди Ш. Новые подходы к лечению немеланотического рака кожи. Альманах клинической медицины. 2007; 15: 235—8.</mixed-citation></ref></ref-list></back></article>
